Crohn's Disease Aggravated

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Crohn's Disease Aggravated trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 3

NCT07149467

Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory Crohn's Disease: A Multic…

Crohn's disease is a chronic inflammatory bowel disorder characterized primarily by abdominal pain and diarrhea \[1,2\]. Conventional treatments include cortico…

Location not specified454 participantsStarted 2025-09-10

Treatment: Ustekinumab (approximately 6 mg/kg), Upadacitinib

Crohn&#39;s Disease Aggravated

Trial phase breakdown

Trial status

All recent trials (1 shown)

Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory Crohn's Disease: A Multic…

Trial phase breakdown

Trial status

All recent trials (1 shown)

Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory Crohn's Disease: A Multic…

Crohn's Disease Aggravated